HUP0100601A3 - Bicyclic compounds containing nitrogen, processes for their preparation and pharmaceutical compositions thereof - Google Patents

Bicyclic compounds containing nitrogen, processes for their preparation and pharmaceutical compositions thereof

Info

Publication number
HUP0100601A3
HUP0100601A3 HU0100601A HUP0100601A HUP0100601A3 HU P0100601 A3 HUP0100601 A3 HU P0100601A3 HU 0100601 A HU0100601 A HU 0100601A HU P0100601 A HUP0100601 A HU P0100601A HU P0100601 A3 HUP0100601 A3 HU P0100601A3
Authority
HU
Hungary
Prior art keywords
processes
preparation
pharmaceutical compositions
compounds containing
containing nitrogen
Prior art date
Application number
HU0100601A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HUP0100601A2 publication Critical patent/HUP0100601A2/hu
Publication of HUP0100601A3 publication Critical patent/HUP0100601A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
HU0100601A 1997-11-28 1998-11-18 Bicyclic compounds containing nitrogen, processes for their preparation and pharmaceutical compositions thereof HUP0100601A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704404A SE9704404D0 (sv) 1997-11-28 1997-11-28 New compounds
PCT/SE1998/002091 WO1999028322A1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof

Publications (2)

Publication Number Publication Date
HUP0100601A2 HUP0100601A2 (hu) 2001-09-28
HUP0100601A3 true HUP0100601A3 (en) 2002-10-28

Family

ID=20409181

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0100601A HUP0100601A3 (en) 1997-11-28 1998-11-18 Bicyclic compounds containing nitrogen, processes for their preparation and pharmaceutical compositions thereof

Country Status (33)

Country Link
US (1) US6518270B1 (hu)
EP (1) EP1042324B1 (hu)
JP (1) JP2001525322A (hu)
KR (1) KR20010032559A (hu)
CN (1) CN1142933C (hu)
AR (1) AR016972A1 (hu)
AT (1) ATE233263T1 (hu)
AU (1) AU752187C (hu)
BR (1) BR9814755A (hu)
CA (1) CA2311798A1 (hu)
CZ (1) CZ292349B6 (hu)
DE (1) DE69811735T2 (hu)
DK (1) DK1042324T3 (hu)
EE (1) EE04060B1 (hu)
ES (1) ES2191356T3 (hu)
HK (1) HK1030216A1 (hu)
HU (1) HUP0100601A3 (hu)
ID (1) ID24730A (hu)
IL (1) IL136145A0 (hu)
IS (1) IS5486A (hu)
MY (1) MY121032A (hu)
NO (1) NO315704B1 (hu)
NZ (1) NZ504355A (hu)
PL (1) PL340920A1 (hu)
PT (1) PT1042324E (hu)
RU (1) RU2241000C2 (hu)
SE (1) SE9704404D0 (hu)
SK (1) SK283904B6 (hu)
TR (1) TR200001530T2 (hu)
TW (1) TW515798B (hu)
UA (1) UA70932C2 (hu)
WO (1) WO1999028322A1 (hu)
ZA (1) ZA9810468B (hu)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE355375T1 (de) 1996-01-04 2006-03-15 Novartis Vaccines & Diagnostic Bakterioferritin aus helicobacter pylori
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
PE20010635A1 (es) * 1999-10-08 2001-08-15 Smithkline Beecham Corp Inhibidores de fab i utiles para el tratamiento de infecciones bacterianas
DE60230934D1 (de) * 2001-04-06 2009-03-05 Affinium Pharm Inc Fab-i-inhibitoren
JP2003119140A (ja) * 2001-08-08 2003-04-23 Sankyo Co Ltd ピロロピリダジン化合物を含有する医薬
WO2003089434A2 (en) * 2002-04-19 2003-10-30 Cellular Genomics, Inc. IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF
US7312341B2 (en) 2002-09-09 2007-12-25 Cgi Pharmaceuticals, Inc. 6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making, and method of use thereof
TW200418479A (en) * 2002-09-25 2004-10-01 Sankyo Co Pharmaceutical compositions for the treatment or prevention of visceral pains
TW200420293A (en) * 2002-09-25 2004-10-16 Sankyo Co Pharmaceutical compositions for the reduction of gastric acid concentration in blood
ES2518316T3 (es) * 2002-12-06 2014-11-05 Debiopharm International Sa Compuestos heterocíclicos, métodos de fabricación de los mismos y su uso en terapia
WO2004072080A1 (en) 2003-02-10 2004-08-26 Cellular Genomics, Inc. Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of hsp90 complex activity
AR043002A1 (es) * 2003-02-18 2005-07-13 Altana Pharma Ag Imidazopirazinas 6-substituidos
DE602004016831D1 (de) * 2003-03-17 2008-11-13 Affinium Pharm Inc Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend
WO2005014599A1 (en) 2003-06-04 2005-02-17 Cellular Genomics, Inc. Imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of bruton’s tyrosine kinase by such compounds
WO2005005429A1 (en) 2003-06-30 2005-01-20 Cellular Genomics, Inc. Certain heterocyclic substituted imidazo[1,2-a]pyrazin-8-ylamines and methods of inhibition of bruton’s tyrosine kinase by such compounds
US7259164B2 (en) 2003-08-11 2007-08-21 Cgi Pharmaceuticals, Inc. Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity
AU2004285394B2 (en) 2003-11-03 2009-01-08 Astrazeneca Ab Imidazo (1,2-A) pyridine derivatives for the treatment of silent gastro-esophageal reflux
CA2568914C (en) * 2004-06-04 2013-09-24 Affinium Pharmaceuticals, Inc. Therapeutic agents, and methods of making and using the same
US20070293532A1 (en) * 2004-07-28 2007-12-20 Takeda Pharmaceutical Compan6Y Limited Pyrrolo [2,3-C] Pyridine Compound, Process for Producing the Same, and Use
JP2008508347A (ja) * 2004-08-02 2008-03-21 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング ５置換された１Ｈ−ピロロ［３，２−ｂ］ピリジン
MX2007002219A (es) * 2004-09-03 2007-05-04 Yuhan Corp Derivados de pirrolo [3,2-b ] piridina y procesos para su preparacion.
DK1784402T3 (da) * 2004-09-03 2011-11-14 Yuhan Corp Pyrrolo[3,2-c]pyridinderivater samt fremgangsmåder til deres fremstilling
CN101018789B (zh) 2004-09-03 2010-09-08 株式会社柳韩洋行 吡咯并[2,3-c]吡啶衍生物及其制备方法
JP4989477B2 (ja) * 2004-09-03 2012-08-01 ユーハン・コーポレイション ピロロ［３，２−ｃ］ピリジン誘導体及びその製造方法
US7777040B2 (en) 2005-05-03 2010-08-17 Cgi Pharmaceuticals, Inc. Certain substituted ureas, as modulators of kinase activity
CA2620223A1 (en) 2005-09-02 2007-03-08 Abbott Laboratories Novel imidazo based heterocycles
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
US7557104B2 (en) 2006-06-06 2009-07-07 Schering Corporation Imidazopyrazines as protein kinase inhibitors
EP2687533B1 (en) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
EP2125802A4 (en) 2007-02-16 2014-08-20 Debiopharm Int Sa SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS
AU2009215191A1 (en) 2008-02-13 2009-08-20 Gilead Connecticut, Inc. 6-aryl-imidaz0[l, 2-a] pyrazine derivatives, method of making, and method of use thereof
US8450321B2 (en) 2008-12-08 2013-05-28 Gilead Connecticut, Inc. 6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
KR20170013414A (ko) 2008-12-08 2017-02-06 질레드 코네티컷 인코포레이티드 이미다조피라진 ｓｙｋ 억제제
CA2745871C (en) 2008-12-08 2018-02-20 Gilead Connecticut, Inc. Imidazopyrazine syk inhibitors
US9562056B2 (en) 2010-03-11 2017-02-07 Gilead Connecticut, Inc. Imidazopyridines Syk inhibitors
PL2861608T3 (pl) 2012-06-19 2019-09-30 Debiopharm International Sa Pochodne prolekowe (e)-n-metylo-n-((3-metylobenzofuran-2-ylo)metylo)-3-(7-okso-5,6,7,8-tetrahydro-1,8-naftyrydyn-3-ylo)akryloamidu
MD4684B1 (ro) 2013-07-30 2020-03-31 Gilead Connecticut INc. Formulări pe bază de imidazopirazine în calitate de inhibitori SYK
US9657023B2 (en) 2013-07-30 2017-05-23 Gilead Connecticut, Inc. Polymorph of Syk inhibitors
EA201690608A1 (ru) 2013-12-04 2016-12-30 Джилид Сайэнс, Инк. Способы лечения раковых заболеваний
GB201321738D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents
TWI662037B (zh) 2013-12-23 2019-06-11 美商基利科學股份有限公司 脾酪胺酸激酶抑制劑
US9290505B2 (en) 2013-12-23 2016-03-22 Gilead Sciences, Inc. Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
NZ726365A (en) 2014-07-14 2018-06-29 Gilead Sciences Inc Combinations for treating cancers
US10751351B2 (en) 2016-02-26 2020-08-25 Debiopharm International S.A. Medicament for treatment of diabetic foot infections
KR102399996B1 (ko) 2017-08-25 2022-05-20 길리애드 사이언시즈, 인코포레이티드 Syk 억제제의 다형체
WO2020172431A1 (en) 2019-02-22 2020-08-27 Gilead Sciences, Inc. Solid forms of condensed pyrazines as syk inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507294A (en) * 1982-03-08 1985-03-26 Schering Corp. Imidazo[1,2-a]pyrazines
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
AU7754691A (en) 1990-04-27 1991-11-27 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel pyridazines
US5041442A (en) * 1990-07-31 1991-08-20 Syntex (U.S.A.) Inc. Pyrrolo(1,2-a)pyrazines as inhibitors of gastric acid secretion
WO1992006979A1 (de) * 1990-10-15 1992-04-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue diazine
EP0609328B1 (de) 1991-10-25 1999-04-28 Byk Gulden Lomberg Chemische Fabrik Gmbh Pyrrolo-pyridazine mit magen- und darmschutzwirkungen
AU680998B2 (en) 1994-01-19 1997-08-14 Sankyo Company Limited Pyrrolopyridazine derivative
SE9602286D0 (sv) 1996-06-10 1996-06-10 Astra Ab New compounds
SE9700661D0 (sv) 1997-02-25 1997-02-25 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds

Also Published As

Publication number Publication date
IS5486A (is) 2000-05-10
KR20010032559A (ko) 2001-04-25
WO1999028322A1 (en) 1999-06-10
BR9814755A (pt) 2000-10-03
RU2241000C2 (ru) 2004-11-27
DE69811735T2 (de) 2003-12-18
UA70932C2 (uk) 2004-11-15
ATE233263T1 (de) 2003-03-15
CN1142933C (zh) 2004-03-24
DE69811735D1 (de) 2003-04-03
AU752187C (en) 2003-09-18
EP1042324B1 (en) 2003-02-26
EE200000315A (et) 2001-10-15
CZ20001947A3 (cs) 2000-11-15
EE04060B1 (et) 2003-06-16
TW515798B (en) 2003-01-01
SE9704404D0 (sv) 1997-11-28
PL340920A1 (en) 2001-03-12
AU1356599A (en) 1999-06-16
CN1284078A (zh) 2001-02-14
IL136145A0 (en) 2001-05-20
DK1042324T3 (da) 2003-05-05
EP1042324A1 (en) 2000-10-11
ES2191356T3 (es) 2003-09-01
SK6742000A3 (en) 2001-03-12
ID24730A (id) 2000-08-03
CZ292349B6 (cs) 2003-09-17
HK1030216A1 (en) 2001-04-27
AU752187B2 (en) 2002-09-12
PT1042324E (pt) 2003-06-30
NO20002721L (no) 2000-07-28
TR200001530T2 (tr) 2000-11-21
SK283904B6 (sk) 2004-04-06
ZA9810468B (en) 1999-05-21
NO315704B1 (no) 2003-10-13
NO20002721D0 (no) 2000-05-26
JP2001525322A (ja) 2001-12-11
MY121032A (en) 2005-12-30
HUP0100601A2 (hu) 2001-09-28
AR016972A1 (es) 2001-08-01
NZ504355A (en) 2001-12-21
US6518270B1 (en) 2003-02-11
CA2311798A1 (en) 1999-06-10

Similar Documents

Publication Publication Date Title
HUP0100601A3 (en) Bicyclic compounds containing nitrogen, processes for their preparation and pharmaceutical compositions thereof
IL131415A (en) Anti-inflammatory compounds, processes for their preparation and pharmaceutical compositions comprising them
HUP0004024A3 (en) Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof
IL145013A0 (en) Tricyclic compounds, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0003844A3 (en) Novel spiroazabicyclic heterocyclic compounds, process for their preparation, their use and pharmaceutical compositions containing them
HUT72448A (en) O-, n- ors-containing heterobicyclic compounds, pharmaceutical compositions comprising them and process for their preparation
HUP0201376A2 (en) Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds
IL115039A (en) Spiroazabicyclic compounds, their preparation and pharmaceutical compositions containing them
IL135920A0 (en) 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor
HUP0001508A3 (en) 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
IL112193A0 (en) Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL109568A0 (en) Urea derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
HUP0203052A3 (en) Bicyclic imidazo-3-yl-amine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0000851A3 (en) Novel pyrimidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
HUP0102512A3 (en) Bridged indenopyrrolocarbazoles, process for their preparation, pharmaceutical compositions containing them and their use
HUP0100488A3 (en) Thienopyrimidines, process for their preparation and pharmaceutical compositions containing them
HUP0203140A3 (en) Bicyclic imidazo-5-yl-amine derivatives, process for their preparation and pharmaceutical compositions containing them
IL137494A0 (en) Polypeptide compounds, process for the preparation thereof and pharmaceutical compositions containing the same
HUP0102215A3 (en) Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation
IL113123A0 (en) Mono- or bicyclic compounds, their preparation and pharmaceutical compositions containing them
IL117620A0 (en) Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same
IL146104A0 (en) Substituted bicyclic heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing the same
HK1039122A1 (zh) 取代的6-苄基-4-氧代嘧啶，其製備方法以及含該化合物的藥物組合物
HUP0003577A3 (en) Tetrahydro gamma-carbolines, process for their preparation, their use and pharmaceutical compositions containing them
HUP0001093A3 (en) Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation